Alnylam Pharmaceuticals, Inc. (ALNY)
159.89
+1.89
(+1.20%)
USD |
NASDAQ |
Nov 03, 16:00
158.59
-1.30
(-0.81%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price : 159.89 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 158.94 | 161.58 | 156.72 | 159.89 | 3.791M |
| Nov 02, 2026 | 163.10 | 163.90 | 156.00 | 158.00 | 4.764M |
| Oct 30, 2026 | 172.70 | 180.61 | 163.30 | 165.00 | 7.057M |
| Oct 29, 2026 | 185.59 | 202.37 | 172.31 | 174.00 | 11.80M |
| Oct 28, 2026 | 222.72 | 232.88 | 220.00 | 232.40 | 1.944M |
| Oct 27, 2026 | 225.00 | 228.49 | 222.82 | 226.79 | 1.603M |
| Oct 26, 2026 | 226.24 | 232.48 | 224.10 | 227.66 | 1.437M |
| Oct 23, 2026 | 227.28 | 229.39 | 222.00 | 224.03 | 1.056M |
| Oct 22, 2026 | 224.92 | 229.82 | 223.76 | 227.28 | 2.212M |
| Oct 21, 2026 | 227.86 | 230.84 | 224.88 | 225.10 | 1.181M |
| Oct 20, 2026 | 237.73 | 238.96 | 229.54 | 230.71 | 1.505M |
| Oct 19, 2026 | 232.64 | 236.54 | 231.26 | 233.29 | 1.344M |
| Oct 16, 2026 | 235.18 | 237.98 | 231.29 | 231.83 | 1.405M |
| Oct 15, 2026 | 230.00 | 234.30 | 228.12 | 234.03 | 1.257M |
| Oct 14, 2026 | 224.49 | 229.56 | 222.25 | 224.47 | 1.106M |
| Oct 13, 2026 | 228.93 | 229.52 | 221.56 | 223.82 | 1.119M |
| Oct 12, 2026 | 233.13 | 233.60 | 226.35 | 227.02 | 916918.0 |
| Oct 09, 2026 | 224.74 | 232.94 | 222.70 | 232.68 | 959451.0 |
| Oct 08, 2026 | 222.03 | 225.90 | 218.39 | 224.53 | 1.772M |
| Oct 07, 2026 | 224.39 | 230.42 | 222.46 | 224.41 | 1.064M |
| Oct 06, 2026 | 221.02 | 229.18 | 217.18 | 223.94 | 1.356M |
| Oct 05, 2026 | 218.36 | 222.08 | 215.46 | 219.89 | 1.281M |
| Oct 02, 2026 | 231.31 | 231.36 | 219.40 | 219.72 | 1.662M |
| Oct 01, 2026 | 248.21 | 251.71 | 230.06 | 231.18 | 2.017M |
| Sep 30, 2026 | 253.68 | 254.44 | 246.66 | 246.74 | 1.044M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 40.42 |
| Vertex Pharmaceuticals, Inc. | 530.76 |
| Pfizer Inc. | 30.00 |
| BridgeBio Pharma, Inc. | 74.03 |
| Cerenome, Inc. | 1.30 |
Price Related Metrics
| PE Ratio | 8.076 |
| PS Ratio | 4.392 |
| PEG Ratio | 0.0034 |
| Price to Book Value | 5.940 |
| Price to Free Cash Flow | 29.27 |
| Earnings Yield | 12.38% |
| Market Cap | 21.41B |
| PEGY Ratio | 0.0034 |
| Operating PE Ratio | 22.52 |
| Normalized PE Ratio | 8.370 |